GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| 
                                                                Synonyms: Tumor necrosis factor ligand superfamily member 15, membrane form
                                 Compound class: 
                                                            Endogenous peptide in human, mouse or rat
                                 
                                    
                                        Comment: TL1A occurs as both membrane‐bound and soluble forms. It principally functions as a negative modulator of epithelial cell proliferation. Inhibiting the TL1A/death receptor 3 (TNFRSF25) pathway has been proposed as mechanism to treat inflammatory bowel disease [1]. In addition, TL1A has been associated with tumourigenesis and progression of some gastrointestinal malignancies  [3,5,7], making it a target of interest for the development of novel anti-cancer drugs.
                                    
                                 
                                    Species: Human
                                 | 
| Natural/Endogenous Targets | ||
| 
 | ||
| Selectivity at catalytic receptors | ||||||||||||||||||||||||||||||||||
| Key to terms and symbols | Click column headers to sort | |||||||||||||||||||||||||||||||||
| 
 | ||||||||||||||||||||||||||||||||||
| Targets where the ligand is described in the comment field | |
| Target | Comment | 
| decoy receptor 3 | Decoy receptor for LIGHT (TNFSF14, O43557), TL1A (TNFSF15, O95150) and Fas ligand (FASLG, P48023). |